174 related articles for article (PubMed ID: 11108433)
1. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.
Lutsar I; Friedland IR
Clin Pharmacokinet; 2000 Nov; 39(5):335-43. PubMed ID: 11108433
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
[TBL] [Abstract][Full Text] [Related]
3. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
Norrby SR
Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
[TBL] [Abstract][Full Text] [Related]
4. Cephalosporins in the treatment of meningitis.
Neu HC
Drugs; 1987; 34 Suppl 2():135-53. PubMed ID: 3319497
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
[TBL] [Abstract][Full Text] [Related]
6. Potential value of cefoperazone in bacterial meningitis: experimental studies.
Durack DT; Perfect JR
Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
Modai J
J Chemother; 1996 Feb; 8 Suppl 2():83-90. PubMed ID: 8738850
[TBL] [Abstract][Full Text] [Related]
8. [The penetration of cephalosporins across the blood-brain barrier and its clinical significance].
Zhang YY; Wu PJ; Zhang Q
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):340-2, 381. PubMed ID: 2582913
[TBL] [Abstract][Full Text] [Related]
9. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
10. Penetration of newer cephalosporins into cerebrospinal fluid.
Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.
Nau R; Prange HW; Kinzig M; Frank A; Dressel A; Scholz P; Kolenda H; Sörgel F
Antimicrob Agents Chemother; 1996 Mar; 40(3):763-6. PubMed ID: 8851607
[TBL] [Abstract][Full Text] [Related]
12. Cefpirome clinical pharmacokinetics.
Strenkoski LC; Nix DE
Clin Pharmacokinet; 1993 Oct; 25(4):263-73. PubMed ID: 8261711
[TBL] [Abstract][Full Text] [Related]
13. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
Scheld WM; Rocha H; Sande MA; Bryan JP
Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
[TBL] [Abstract][Full Text] [Related]
15. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic pharmacodynamics in cerebrospinal fluid.
Lutsar I; McCracken GH; Friedland IR
Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
[TBL] [Abstract][Full Text] [Related]
17. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the penetration of antimicrobial agents into the cerebrospinal fluid of experimental animals.
Sande MA; Sherertz RJ; Zak O; Dacey RG; Bodine JA; Strausbaugh LJ
Scand J Infect Dis Suppl; 1978; (14):160-3. PubMed ID: 279968
[TBL] [Abstract][Full Text] [Related]
19. Investigations of cefuroxime levels in cerebrospinal fluid of patients with and without meningitis.
Friedrich H; Haensel-Friedrich G; Langmaak H; Daschner FD
Chemotherapy; 1980; 26(2):91-7. PubMed ID: 7363711
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
